Lou Garrison

• Health Policy and Regulation
• Innovation
• PhRMA
• Policy Analysis
• US

The Lower Drug Costs Now Act and Pharmaceutical Innovation

Read more

• Economic Evaluation
• Mexico
• PhRMA
• Resource Allocation
• Emerging Markets
• Health Care Systems
• Use of Medicines

Policy Options for Formulary Development in Middle-income Countries

Read more

• Economic Evaluation
• Mexico
• PhRMA
• Resource Allocation
• Emerging Markets
• Health Care Systems
• Use of Medicines

Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study

Read more

• Cancer
• HTA
• Innovation
• NICE
• Oncology
• Health Technology Assessment…

The Expanding Value Footprint of Oncology Treatments

Read more

• Determining Value
• Diagnostics and Imaging
• External Publications
• Value-Based Pricing

Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?

Read more